These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 15617731
1. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Chauhan NB, Siegel GJ, Feinstein DL. Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731 [Abstract] [Full Text] [Related]
9. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Li L, Liu Z, Liu J, Tai X, Hu X, Liu X, Wu Z, Zhang G, Shi M, Zhao G. Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003 [Abstract] [Full Text] [Related]
10. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. Long ZM, Zhao L, Jiang R, Wang KJ, Luo SF, Zheng M, Li XF, He GQ. CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876 [Abstract] [Full Text] [Related]
12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J, Levy M, Dickson DW, Potter H. Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [Abstract] [Full Text] [Related]
13. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A. Mol Brain; 2015 Dec 04; 8(1):82. PubMed ID: 26637371 [Abstract] [Full Text] [Related]
14. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Dionísio PA, Amaral JD, Ribeiro MF, Lo AC, D'Hooge R, Rodrigues CM. Neurobiol Aging; 2015 Jan 04; 36(1):228-40. PubMed ID: 25443293 [Abstract] [Full Text] [Related]
15. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S. J Alzheimers Dis; 2010 Jan 04; 19(2):691-704. PubMed ID: 20110613 [Abstract] [Full Text] [Related]
16. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF, Mao QQ, Wu JC, Su ZR, Chen JN, Lai XP, Ip SP, Lin ZX. J Alzheimers Dis; 2014 Jan 04; 39(2):331-46. PubMed ID: 24164737 [Abstract] [Full Text] [Related]
17. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice. Sun J, Zhang X, Wang C, Teng Z, Li Y. Am J Chin Med; 2017 Jan 04; 45(8):1667-1682. PubMed ID: 29132216 [Abstract] [Full Text] [Related]
18. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Jin G, Wang LH, Ji XF, Chi TY, Qi Y, Jiao Q, Xu Q, Zhou XY, Zhang R, Zou LB. Neurosci Lett; 2014 Jun 24; 573():58-63. PubMed ID: 24810883 [Abstract] [Full Text] [Related]
19. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease. Lanzillotta A, Sarnico I, Benarese M, Branca C, Baiguera C, Hutter-Paier B, Windisch M, Spano P, Imbimbo BP, Pizzi M. J Mol Neurosci; 2011 Sep 24; 45(1):22-31. PubMed ID: 21181298 [Abstract] [Full Text] [Related]